These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 16575232
1. Beyond MRSA: VISA and VRSA: what will ward off these pathogens in health care facilities? Todd B. Am J Nurs; 2006 Apr; 106(4):28-30. PubMed ID: 16575232 [No Abstract] [Full Text] [Related]
2. MRSA and VRSA in wound care: accept the challenge. McGuckin M. Adv Skin Wound Care; 2004 Mar; 17(2):93-5. PubMed ID: 15021095 [No Abstract] [Full Text] [Related]
3. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know. McDonald LC, Hageman JC. Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615 [Abstract] [Full Text] [Related]
10. Antimicrobial resistance takes another step forward. Maskalyk J. CMAJ; 2002 Aug 20; 167(4):375. PubMed ID: 12197696 [No Abstract] [Full Text] [Related]
11. MRSA cases halved within four years? Just how realistic is the new target? O'Dowd A. Nurs Times; 2002 Aug 20; 100(46):12-3. PubMed ID: 15595478 [No Abstract] [Full Text] [Related]
12. MRSA hotspots. Leifer D. Nurs Stand; 2002 Aug 20; 19(52):20-1. PubMed ID: 16163978 [Abstract] [Full Text] [Related]
13. Understanding and controlling methicillin-resistant Staphylococcus aureus infections. Boyce JM. Infect Control Hosp Epidemiol; 2002 Sep 20; 23(9):485-7. PubMed ID: 12269442 [No Abstract] [Full Text] [Related]
14. Transmission and epidemiology of MRSA: current perspectives. Banning M. Br J Nurs; 2002 Sep 20; 14(10):548-51, 554. PubMed ID: 15928571 [Abstract] [Full Text] [Related]
15. [Methicillin resistant staphylococcus aureus (MRSA): incidence is growing in French-speaking Switzerland]. Blanc DS, Troillet N, Siegrist HH, Fracheboud D, Petignat C, Francioli P. Rev Med Suisse Romande; 2001 Apr 20; 121(4):309-12. PubMed ID: 11400404 [No Abstract] [Full Text] [Related]
16. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Zhanel GG, Voth D, Nichol K, Karlowsky JA, Noreddin AM, Hoban DJ. J Antimicrob Chemother; 2009 Aug 20; 64(2):364-9. PubMed ID: 19454524 [Abstract] [Full Text] [Related]
17. Multicentre surveillance of antibiotic resistance in nosocomial Staphylococcus aureus in Cyprus. Gourni M, Kontou M, Hadjipanayiotou C, Protopapa P. East Mediterr Health J; 2001 Aug 20; 7(4-5):744-9. PubMed ID: 15332774 [Abstract] [Full Text] [Related]
18. Best-practice protocols: reducing harm from MRSA. Richmond I, Bernstein A, Creen C, Cunningham C, Rudy M. Nurs Manage; 2007 Aug 20; 38(8):22-7. PubMed ID: 17700318 [No Abstract] [Full Text] [Related]
19. Controlling a multicenter outbreak involving the New York/Japan methicillin-resistant Staphylococcus aureus clone. Coombs GW, Van Gessel H, Pearson JC, Godsell MR, O'Brien FG, Christiansen KJ. Infect Control Hosp Epidemiol; 2007 Jul 20; 28(7):845-52. PubMed ID: 17564988 [Abstract] [Full Text] [Related]
20. Fighting MRSA in hospitals: time to restrict the broad use of specific antimicrobial classes? Monnet DL, MacKenzie FM, Skov R, Jensen ET, Gould IM, Frimodt-Møller N. J Hosp Infect; 2005 Nov 20; 61(3):267-8. PubMed ID: 16009460 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]